World's Best Scientists 2026 revealed!
Hironobu Ihn

Hironobu Ihn

D-Index & Metrics

Medicine

D-Index
77
Citations
20830
World Ranking
18471
National Ranking
592

Hironobu Ihn publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Hironobu Ihn sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 582 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Hironobu Ihn D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Hironobu Ihn sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Hironobu Ihn is affiliated with Kumamoto University in Japan and has contributed extensively to the field of medicine, with a focus on oncology, dermatology, immunology, epidemiology, and pathology. Their research spans various subfields, reflecting a broad and interdisciplinary approach to medical science.

The scientist's work concentrates on key topics such as immunotherapy and immune responses, systemic sclerosis and related diseases, cancer and skin lesions, dermatologic treatments and research, nail diseases and treatments, fungal infections and studies, and vascular tumors and angiosarcomas.

Several recent papers illustrate the scope and focus of Hironobu Ihn's research. These include:

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial, 2020, The Lancet Respiratory Medicine
  • Skin microbiome in acral melanoma: Corynebacterium is associated with advanced melanoma, 2020, The Journal of Dermatology
  • Cutaneous lymphoma in Japan, 2012-2017: A nationwide study, 2020, Journal of Dermatological Science
  • Circulating tumor necrosis factor-α DNA are elevated in psoriasis, 2020, The Journal of Dermatology
  • Significance of 5-S-Cysteinyldopa as a Marker for Melanoma, 2020, International Journal of Molecular Sciences

Hironobu Ihn has frequently published in several notable scientific journals. The most common publication venues include:

  • The Journal of Dermatology
  • Journal of Dermatological Science
  • International Journal of Molecular Sciences
  • Modern Rheumatology
  • Japanese Journal of Clinical Oncology

The scientist has collaborated multiple times with a number of coauthors. Frequently recurring collaborators in their research are:

  • Satoshi Fukushima
  • Ikko Kajihara
  • Katsunari Makino
  • Jun Aoi
  • Hisashi Kanemaru

Hironobu Ihn's extensive publication record includes over 100 works primarily in medicine. The main field of study, medicine, is complemented by significant contributions to oncology, dermatology, immunology, epidemiology, and pathology.

Best Publications

  • Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders

    Atsuyuki Igarashi;Kiyoko Nashiro;Kanako Kikuchi;Shinichi Sato

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression

    Masatoshi Jinnin;Hironobu Ihn;Kunihiko Tamaki

  • Pathogenesis of fibrosis: role of TGF-beta and CTGF.

    Hironobu Ihn

  • Significant Correlation Between Connective Tissue Growth Factor Gene Expression and Skin Sclerosis in Tissue Sections from Patients with Systemic Sclerosis

    Atsuyuki Igarashi;Kiyoko Nashiro;Kanako Kikuchi;Shinichi Sato

  • Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.

    Hirotake Tsukamoto;Koji Fujieda;Azusa Miyashita;Satoshi Fukushima

  • Increased Expression of TGF-β Receptors by Scleroderma Fibroblasts: Evidence for Contribution of Autocrine TGF-β Signaling to Scleroderma Phenotype

    Tamihiro Kawakami;Hironobu Ihn;Weidong Xu;Edwin Smith

  • Increased Expression of Integrin αvβ3 Contributes to the Establishment of Autocrine TGF-β Signaling in Scleroderma Fibroblasts

    Yoshihide Asano;Hironobu Ihn;Kenichi Yamane;Masatoshi Jinnin

  • A randomized double-blind trial of intravenous immunoglobulin for pemphigus

    Masayuki Amagai;Shigaku Ikeda;Hiroshi Shimizu;Hajime Iizuka

  • Impaired Smad7-Smurf–mediated negative regulation of TGF-β signaling in scleroderma fibroblasts

    Yoshihide Asano;Hironobu Ihn;Kenichi Yamane;Masahide Kubo

  • Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis

    Nobuyo Higashi-Kuwata;Masatoshi Jinnin;Takamitsu Makino;Satoshi Fukushima

  • Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts

    Taiji Nakashima;Masatoshi Jinnin;Keitaro Yamane;Noritoshi Honda

  • The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker

    Hisashi Kanemaru;Satoshi Fukushima;Junji Yamashita;Noritoshi Honda

  • Blockade of endogenous transforming growth factor β signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: Association with increased expression of transforming growth factor β receptors

    Hironobu Ihn;Kenichi Yamane;Masahide Kubo;Kunihiko Tamaki

  • Myasthenic crisis and polymyositis induced by one dose of nivolumab

    Toshihiro Kimura;Satoshi Fukushima;Azusa Miyashita;Jun Aoi

  • Increased Expression of Integrin αvβ5 Induces the Myofibroblastic Differentiation of Dermal Fibroblasts

    Yoshihide Asano;Hironobu Ihn;Kenichi Yamane;Masatoshi Jinnin

  • Transcriptional Regulation of the Human α2(I) Collagen Gene COMBINED ACTION OF UPSTREAM STIMULATORY AND INHIBITORY CIS-ACTING ELEMENTS

    Hironobu Ihn;Kazunori Ohnishi;Takeshi Tamaki;E. Carwile LeRoy

  • The Downregulation of microRNA let-7a Contributes to the Excessive Expression of Type I Collagen in Systemic and Localized Scleroderma

    Katsunari Makino;Masatoshi Jinnin;Ayaka Hirano;Keitaro Yamane

  • TGF-β–Mediated Downregulation of MicroRNA-196a Contributes to the Constitutive Upregulated Type I Collagen Expression in Scleroderma Dermal Fibroblasts

    Noritoshi Honda;Masatoshi Jinnin;Ikko Kajihara;Takamitsu Makino

  • Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis

    Minoru Hasegawa;Shinichi Sato;Manabu Fujimoto;Hironobu Ihn

Frequent Co-Authors

Masatoshi Jinnin
Masatoshi Jinnin Wakayama Medical University
Kunihiko Tamaki
Kunihiko Tamaki University of Tokyo
Yoshihide Asano
Yoshihide Asano University of Tokyo
Manabu Fujimoto
Manabu Fujimoto Osaka University
Shinichi Sato
Shinichi Sato University of Tokyo
Minoru Hasegawa
Minoru Hasegawa University of Fukui
Kazuhiko Takehara
Kazuhiko Takehara Kanazawa University
Takafumi Kadono
Takafumi Kadono St. Marianna University School of Medicine
Kazuya Kikuchi
Kazuya Kikuchi Osaka University
Masataka Kuwana
Masataka Kuwana Nippon Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online programs can open diverse opportunities for those interested in medicine and healthcare careers in the USA. For those aiming for leadership roles, pursuing cahme accredited mha online programs is a smart move, as these programs ensure high educational standards for health administration degrees.

Nursing professionals seeking advancement without stepping away from work might consider rn bsn online programs no clinicals, which provide flexibility by minimizing in-person requirements. If you’re after a faster route to the highest level of nursing practice, there are 1 year dnp program online options that help you achieve your degree efficiently.

Affordability is another important factor. Several cheapest dnp programs exist, making advanced credentials accessible without overwhelming financial burdens. Carefully researching and choosing the right online degree pathway can set the stage for a successful and flexible healthcare career in the USA.

Best Scientists Citing Hironobu Ihn

Trending Scientists

Recently Published Articles